Caris Life Sciences, Inc. Common Stock Net Asset Quality Index
Caris Life Sciences, Inc. Common Stock net asset quality index. Caris Life Sciences, Inc. Common Stock (CAI) has a Net Asset Quality Index of 48.1% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $1.23 Billion minus total liabilities of $637.89 Million yields net assets of $591.73 Million. A higher index indicates a stronger, lower-leverage balance sheet. See CAI net assets for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Caris Life Sciences, Inc. Common Stock (2003–2025)
Net asset quality index of Caris Life Sciences, Inc. Common Stock from 2003 to 2025. This chart shows how Caris Life Sciences, Inc. Common Stock's Net Asset Quality Index has evolved across 22 annual periods from 2003 to 2025. As of June 2026, the index stands at 48.1%, representing net assets of $591.73 Million against total assets of $1.23 Billion USD. Check CAI intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Caris Life Sciences, Inc. Common Stock Net Asset Quality Index by Year (2003–2025)
Caris Life Sciences, Inc. Common Stock net asset quality index by year from 2003 to 2025. The table below presents the year-by-year Net Asset Quality Index for Caris Life Sciences, Inc. Common Stock from 2003 to 2025, covering 22 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Caris Life Sciences, Inc. Common Stock stock valuation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 51.3% | $577.31 Million | $1.13 Billion | $548.36 Million | ▲ +778.3 pp |
| 2024 | -727.0% | $-2.50 Billion | $343.73 Million | $2.84 Billion | ▼ -207.5 pp |
| 2023 | -519.5% | $-2.14 Billion | $412.90 Million | $2.56 Billion | ▼ -282.2 pp |
| 2022 | -237.3% | $-1.70 Billion | $717.42 Million | $2.42 Billion | ▼ -264.1 pp |
| 2020 | 26.9% | $702.24 Million | $2.61 Billion | $1.91 Billion | ▲ +3.0 pp |
| 2019 | 23.9% | $693.24 Million | $2.90 Billion | $2.21 Billion | ▲ +0.6 pp |
| 2018 | 23.3% | $701.13 Million | $3.01 Billion | $2.31 Billion | ▲ +0.1 pp |
| 2017 | 23.2% | $563.85 Million | $2.43 Billion | $1.87 Billion | ▲ +0.9 pp |
| 2016 | 22.3% | $457.50 Million | $2.06 Billion | $1.60 Billion | ▼ -1.0 pp |
| 2015 | 23.2% | $461.26 Million | $1.99 Billion | $1.53 Billion | ▼ -1.4 pp |
| 2014 | 24.7% | $442.90 Million | $1.80 Billion | $1.35 Billion | ▼ -0.1 pp |
| 2013 | 24.8% | $415.13 Million | $1.68 Billion | $1.26 Billion | ▼ -0.2 pp |
| 2012 | 25.0% | $346.85 Million | $1.39 Billion | $1.04 Billion | ▼ -1.1 pp |
| 2011 | 26.1% | $248.74 Million | $953.37 Million | $704.63 Million | ▼ -6.1 pp |
| 2010 | 32.2% | $197.67 Million | $613.45 Million | $415.78 Million | ▼ -2.3 pp |
| 2009 | 34.5% | $129.10 Million | $374.08 Million | $244.99 Million | ▲ +6.9 pp |
| 2008 | 27.6% | $113.79 Million | $412.63 Million | $298.84 Million | ▼ -8.9 pp |
| 2007 | 36.5% | $131.15 Million | $359.10 Million | $227.95 Million | ▲ +26.7 pp |
| 2006 | 9.8% | $27.75 Million | $283.00 Million | $255.25 Million | ▼ -8.5 pp |
| 2005 | 18.3% | $32.99 Million | $180.66 Million | $147.67 Million | ▲ +5.2 pp |
| 2004 | 13.1% | $23.82 Million | $181.96 Million | $158.14 Million | ▲ +5.2 pp |
| 2003 | 7.9% | $15.18 Million | $193.10 Million | $177.92 Million | — |